Site Search
Company Search
Get Quote
The SeriousTraders Newsletter If you are Serious about Trading, become a SeriousTrader!™
SeriousTradersSpotlight Company
VistaGen Therapeutics Inc. (NASDAQ: VTGN)
Investment Considerations VistaGen’s product portfolio consists of three novel drug candidates that, together, target multiple anxiety disorders, depression disorders and neurological disorders. Two of the company’s drug candidates have received an FDA fast track designation, including for the treatment of social anxiety disorder, major depressive disorder and neuropathic pain. The global CNS therapeutics market is … Continue reading “VistaGen Therapeutics Inc. (NASDAQ: VTGN)”
Latest Press Releases
Filter Releases
| Symbol | Release | Time |
|---|---|---|
| {{ release.qmtopics.qmsymbol[0].symbol }} | {{ release.headline }} | {{ release.datetime | amDateFormat:'hh:mm A'}} |
SeriousTraders is part of the IBN (InvestorBrandNetwork). Other brands within the investor brand network include:
